fluxd
.news
Soligenix receives EU orphan drug status for Behçet’s disease treatment · fluxd.news
fluxd
.news
LIVE
☽
Terms
Privacy
Cookies
☰
Back to Feed
Fintech
Soligenix receives EU orphan drug status for Behçet’s disease treatment
Investing
·
March 26, 2026 at 11:38 AM
Original Source
Investing — www.investing.com
Share
Related in Fintech
Wells Fargo virtual assistant aids over 1 billion transactions
PYMNTS
White House crypto czar joins science advisory committee
CoinDesk
David Sacks leaves crypto post for White House
The Block
Lawmakers Question Bank Regulators on Fintech Rules
PYMNTS